Pharmacopeia's drug discovery model

Pharmacopeia Inc. has raised $10.3 million in a second round of venture financing for its approach to drug discovery, which uses combinatorial chemistry to generate libraries of small molecules, a model designed to appeal to a restructuring pharmaceutical industry.

President and Chief Scientific Officer John Chabala told BioCentury that the rationale for Pharmacopeia is the notion that the paradigm for drug discovery is changing. Success in the pharmaceutical business, the company